October 2, 2015

Why Drug Prices Are Out of Control, And What We Can Do About It

Jamie Love of Knowledge Ecology International told the Real News that our system does little to curb outrageous drug prices, and it's not because there aren't good alternatives
Members don't see ads. If you are a member, and you're seeing this appeal, click here

Share to Facebook Share to Twitter

I support The Real News Network because I am tired of lies and biased journalism. Long live TRNN! - Roberto
Log in and tell us why you support TRNN


Why Drug Prices Are Out of Control, And What We Can Do About ItWell, it used to--it used to be a lot more journalism around these various scandals. Certainly the '80s and the '90s you'd be, you saw more investigative work on these kind of corporate malfeasance stories, or drug pricing scandals and things like that.

I think one thing that's changed now is a lot of people are insured. And when there's a lot of people are insured there may be a problem in the price of the drug, but they may not experience it themselves. So if a drug goes from $13 to $750 a pill, or if a treatment cost $84,000 or $184,000, what the patient's really looking at is what, what their co-payment is. And as long as they have insurance and the insurance covers it, they don't really complain too much. What they really want to know is are they in or out of the system. It's pretty painful if you're out. But if you're in then you just feel like, okay, it's not my problem anymore.

Collectively it's evryone's problem. I mean, the reason why we pay so much for insurance is because it's just become, prices have become out of control.

Eventually you begin to see sort of the predictable backlash. Which is to say, it's harder and harder to get certain products covered by insurance, the co-payments are higher, and the--you can't experiment with cancer drugs on patients as easily because the insurance company won't allow you to try a drug that doesn't have a strong approval even though you might benefit from it.

If you think we have about a trillion dollars of a drug market, less than 8 percent of that is reinvested by the private sector back into R&D for new drugs. Of that 8 percent that's reinvested less than half of that is invested in products that have any kind of medical benefits that anybody cares about. There's a certain amount of money that's just disguised bribes to doctors. And consulting fees on clinical trials that is really just about getting favor with doctors that prescribe your products. All of that's good from a commercial point of view but it doesn't really do anything for medical outcomes.

One sort of interpretation is that the White House figures that we're, Americans, we're the sellers of drugs. We have companies like Pfizer and Merck and Johnson and Johnson. So we should push for high prices everywhere because we would benefit more than it would hurt us. The pharmaceutical industry is not the whole U.S. economy. And yet for the trade agreement they're almost the whole enchilada. I mean, like, basically the biggest demand the United States has in the trade agreement is to give big pharma what it wants. That's coming at the expense of things for auto workers and for other sectors of the economy that are going to be disadvantaged by the trade agreement.

If you look at the CEOs of companies, old school would be CEOs that knew something about the industry itself, that worked in, you know, as an engineer or as a, they were doctors or things like that. Like Roy Vagelos from, is that how you say his name? Former CEO of Merck, was one of these sort of old-school guys. Now you see these people that come in. Pfizer for a while they had a CEO that came out of business school, then they had a lawyer running the firm. Novartis fired one of their guys and replaced him with a ketchup salesman. I mean, now people running the firms are just, you know, their basically expertise is in marketing, sometimes finance. And it's just, they're just, they're just trying to--you know, they have assets. The assets are whatever products they have, which are whatever drugs they have. And they just figure out how to make as much money from them as possible.

Pharmaceutical drugs should be generic drugs. They should be generic drugs all the time. You'd have to replace, taking away the monopoly system. You'd have to create a separate way to pay off the innovation. And that's not that difficult to do for drugs. You can have a fund that rewards innovation, that looks the the same type of information that's used right now as a reality check on, on reimbursements for high prices. Just to make it more concrete, you can de-link the way that you finance R&D from the price of the drug that the patient sees.


DISCLAIMER: Please note that transcripts for The Real News Network are typed from a recording of the program. TRNN cannot guarantee their complete accuracy.


Our automatic spam filter blocks comments with multiple links and multiple users using the same IP address. Please make thoughtful comments with minimal links using only one user name. If you think your comment has been mistakenly removed please email us at

latest stories

Growing Discontent with Corruption Brings Thousands of Russians to the Streets
Will Dems Derail Sanders's Push for Public Option?
Arrest of Omar Barghouti Comes Amidst Upsurge in International Support for Boycott of Israel
Baltimore Mayor's Veto of $15/Hr Bill Shows Corporate Wing of Democrats Alive and Well
Military-Industrial Complex Pushes Nuke Modernization, Risking Confrontation with Russia
Empire Files: The Sikh Experience in America
Nebraskan Landowners Resist Keystone XL By Refusing to Sell Their Property to TransCanada
Study Links Extreme Weather Events to Climate Change
Sixth Year of War in Syria Marked by Tremendous Civilian Casualties
The Protest-Resignation of UN Under-Secretary Dr. Rima Khalaf
Climate Catastrophe Is Here: 2016 Hottest Year on Record
Millions for Prisoners Human Rights March in D.C. Set for August
"Wealthcare" Defeated: Health Care For All Back on the Agenda
Defending the Climate in the Age of Trump
Baltimore Public School Funding Pales in Comparison to Private Education Spending
Rattling the Bars: Women and Incarceration
Trump-Republican Alliance in Disarray?
Baltimore Mayor's Veto of $15 Wage Protects Policy of Subsidizing Wealthy, Councilperson Says
The Truth Behind the War on Immigrants
Were Haitian Police Behind Assassination Attempt on Aristide?
New Provisions Eliminate Healthcare From GOP 'Wealthcare' Bill
Why Further Revelations on Trump's Russian Connections Might Fail to Bring Him Down
18 Million U.S. Citizens Exposed to Lead-Contaminated Water Systems
Russia vs. USA: Who is the Threat, Who is the Aggressor? (2/2)
Should Sanders Continue the Fight Outside the Democratic Party?
Fed Inflation Target Keeping Wages Low, People Out of Jobs
Is Trump Dangerous for Russia?
Was the Georgian Conflict Started to Elect John McCain President in 2008? Pt.1
Will the NDP Adopt Pro-BDS Platform?
Massive Cuts to EPA Threaten Communities Already Suffering From Pollution, Climate Change,, The Real News Network, Real News Network, The Real News, Real News, Real News For Real People, IWT are trademarks and service marks of Independent World Television inc. "The Real News" is the flagship show of IWT and The Real News Network.

All original content on this site is copyright of The Real News Network. Click here for more

Problems with this site? Please let us know

Managed Wordpress Hosting